congress
presentations
Boston, Massachusetts
October 29-November 2, 2024
Solriamfetol | Excessive Daytime Sleepiness
Solriamfetol | Excessive Daytime Sleepiness
Solriamfetol | Excessive Daytime Sleepiness
AXS-05 | Major Depressive Disorder
AXS-05 | Major Depressive Disorder
AXS-05 | Major Depressive Disorder
Major Depressive Disorder
AXS-05 | Alzheimer’s Disease Agitation